The following sections discuss the structure of mucin glycans, their biosynthetic pathways, roles in barrier function, aberrant glycosylation patterns in colonic diseases, and emerging glycosylation-targeted therapeutic strategies. The gene discussed is MUC5AC; the disease is colonic disorder.